Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Clinical trial NCT05538091 · RECRUITING

Trial details

NCT number: NCT05538091
Sponsor: Ronald Buckanovich
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum-Resistant Fallopian Tube Carcinoma Platinum-Resistant Primary Peritoneal Carcinoma PARP Inhibitor Hedgehog Inhibitor

Start date: 2023-05-15
Primary completion: 2031-08-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.